Please use this identifier to cite or link to this item:
|Title:||Polymorphisms in cytokine genes IL6, TNF, IL10, IL17A and IFNG influence susceptibility to complicated skin and skin structure infections||Authors:||STAPPERS, Mark
Plantinga, T. S.
Mouton, J. W.
Netea, M. G.
Joosten, L. A. B.
|Issue Date:||2014||Publisher:||SPRINGER||Source:||EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 33 (12), p. 2267-2274||Abstract:||Complicated skin and skin structure infections (cSSSIs) are caused by Gram-positive and Gram-negative, aerobic and anaerobic pathogens, with a polymicrobial aetiology being frequent. Recognition of invading pathogens by the immune system results in the production of pro- and anti-inflammatory cytokines, which are extremely important for intercellular communication and control of infection. This study assessed whether genetic variation in genes encoding cytokines influences the susceptibility to cSSSIs. For the association study, 318 patients with cSSSI and 328 healthy controls were genotyped for single nucleotide polymorphisms (SNPs) in cytokine genes IL1A, IL1B, IL1RN, TNF, IL10, IL17A, IL17F and IFNG. For immunological validation, peripheral blood mononuclear cells (PBMCs) from 74 healthy individuals, genotyped for SNPs of interest, were stimulated with Staphylococcus aureus or Escherichia coli and corresponding cytokine levels were determined by enzyme-linked immunosorbent assay (ELISA). Polymorphisms IL6 rs1800797, TNF rs1800629, IL10 rs1800871, IL17A rs8193036 and IFNG rs2069705 influenced susceptibility to cSSSIs. No differences in cytokine responses, stratified for genotype, were detected after PBMC stimulation. No association with cSSSIs was observed for polymorphisms IL1A rs17561 and rs1800587, IL1B rs16944 and rs1143627, IL1RN rs4251961, TNF rs361525, IL10 rs1800896, IL17A rs2275913 and IL17F rs763780. In conclusion, polymorphisms in IL6, TNF, IL10, IL17A and IFNG are associated with susceptibility to cSSSIs.||Notes:||[Stappers, M. H. T.; Thys, Y.; Oosting, M.; Plantinga, T. S.; Ioana, M.; Netea, M. G.; Joosten, L. A. B.; Gyssens, I. C.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med 463, NL-6500 HB Nijmegen, Netherlands. [Mouton, J. W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands. [Stappers, M. H. T.; Mouton, J. W.; Gyssens, I. C.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands. [Stappers, M. H. T.; Thys, Y.; Gyssens, I. C.] Hasselt Univ, Hasselt, Belgium. [Reimnitz, P.] Bayer Healthcare Pharmaceut, Wuppertal, Germany. [Mouton, J. W.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.||Document URI:||http://hdl.handle.net/1942/18087||ISSN:||0934-9723||e-ISSN:||1435-4373||DOI:||10.1007/s10096-014-2201-0||ISI #:||000345138300022||Rights:||© Springer-Verlag Berlin Heidelberg 2014.||Category:||A1||Type:||Journal Contribution||Validations:||ecoom 2015|
|Appears in Collections:||Research publications|
Show full item record
Files in This Item:
|292.53 kB||Adobe PDF||View/Open Request a copy|
checked on Sep 7, 2020
WEB OF SCIENCETM
checked on May 21, 2022
checked on May 19, 2022
checked on May 19, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.